Int J Med Sci 2024; 21(3):454-463. doi:10.7150/ijms.87167 This issue Cite

Research Paper

A Retrospective Study on COVID-19 Infections Caused by Omicron Variant with Clinical, Epidemiological, and Viral Load Evaluations in Breakthrough Infections

Jian Liu1,2*, Ru Wen1,2,3*, Nanzhu Wang1*, Guizhou Li4, Peng Xu2, Xiaoming Li2✉, Xianchun Zeng1✉, Chen Liu2✉

1. Department of Medical Imaging, Guizhou Provincial People Hospital, Guiyang City, Guizhou Province, 550000, China.
2. Department of Radiology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
3. Medical College, Guizhou University, Guizhou,550000, China.
4. College of Mathematics and Statistics, Chongqing University, Chongqing, 400044, China.
* Jian Liu, Ru Wen, Nanzhu Wang contributed equally to this work.

Citation:
Liu J, Wen R, Wang N, Li G, Xu P, Li X, Zeng X, Liu C. A Retrospective Study on COVID-19 Infections Caused by Omicron Variant with Clinical, Epidemiological, and Viral Load Evaluations in Breakthrough Infections. Int J Med Sci 2024; 21(3):454-463. doi:10.7150/ijms.87167. https://www.medsci.org/v21p0454.htm
Other styles

File import instruction

Abstract

Graphic abstract

Purpose: To explore the clinical, epidemiological, and viral load characteristics of COVID-19 caused by the omicron variant.

Methods: Based on the COVID-19 epidemic caused by SARS-CoV-2 Omicron BA.2 broke out in Shanghai, China. To analyze whether there is any association between clinical symptoms and viral load of COVID-19 with age, sex, and combined disease and whether the clinical symptoms and viral load are associated with vaccine-breakthrough infections.

Results: The most common symptoms were cough, expectoration, and fatigue, which were more common in women than males (p < 0.001). The average viral clearance time in the > 75 years group was the longest (6.64 days). The viral load in the 60-75 years group was significantly higher than that in the other groups (p < 0.001). The 18-45 years old group had the most clinical symptoms at admission (45.39%). The days of nucleic acid-negative conversion, average viral load, highest viral load, and clinical symptoms in comorbid chronic disease patients are longer (p < 0.001). The average and highest viral loads in the unvaccinated group were longer than those in the vaccine breakthrough infection groups (p < 0.001). However, the clinical symptoms in the vaccine breakthrough infection group were significantly more severe than those in the unvaccinated group (p < 0.001).

Conclusions: We found that female patients, the elderly, and those with underlying comorbidities had longer clinical positive symptoms and viral loads. Although vaccination may not reduce clinical symptoms, it can shorten the viral load and the time required for virus clearance.

Keywords: Omicron, Viral load, Ct-value, gender, age, comorbidities, vaccination, Clinical symptoms


Citation styles

APA
Liu, J., Wen, R., Wang, N., Li, G., Xu, P., Li, X., Zeng, X., Liu, C. (2024). A Retrospective Study on COVID-19 Infections Caused by Omicron Variant with Clinical, Epidemiological, and Viral Load Evaluations in Breakthrough Infections. International Journal of Medical Sciences, 21(3), 454-463. https://doi.org/10.7150/ijms.87167.

ACS
Liu, J.; Wen, R.; Wang, N.; Li, G.; Xu, P.; Li, X.; Zeng, X.; Liu, C. A Retrospective Study on COVID-19 Infections Caused by Omicron Variant with Clinical, Epidemiological, and Viral Load Evaluations in Breakthrough Infections. Int. J. Med. Sci. 2024, 21 (3), 454-463. DOI: 10.7150/ijms.87167.

NLM
Liu J, Wen R, Wang N, Li G, Xu P, Li X, Zeng X, Liu C. A Retrospective Study on COVID-19 Infections Caused by Omicron Variant with Clinical, Epidemiological, and Viral Load Evaluations in Breakthrough Infections. Int J Med Sci 2024; 21(3):454-463. doi:10.7150/ijms.87167. https://www.medsci.org/v21p0454.htm

CSE
Liu J, Wen R, Wang N, Li G, Xu P, Li X, Zeng X, Liu C. 2024. A Retrospective Study on COVID-19 Infections Caused by Omicron Variant with Clinical, Epidemiological, and Viral Load Evaluations in Breakthrough Infections. Int J Med Sci. 21(3):454-463.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image